相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypertriglyceridemia and lipid tolerance in preterm infants with a birth weight of less than 1250 g on routine parenteral nutrition
Ilaria Giretti et al.
CLINICAL NUTRITION (2021)
PPARγ activation in late gestation does not promote surfactant maturation in the fetal sheep lung
Jiaqi Ren et al.
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (2021)
PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage
Sunil Krishna et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Simvastatin attenuates lung functional and vascular effects of hyperoxia in preterm rabbits
Thomas Salaets et al.
PEDIATRIC RESEARCH (2020)
Antenatal PPAR-γ agonist pioglitazone stimulates fetal lung maturation equally in males and females
Cindy Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Intratracheal budesonide/surfactant attenuates hyperoxia-induced lung injury in preterm rabbits
Andre G. Gie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension
Rajamma Mathew
CHILDREN-BASEL (2020)
Preterm birth impairs postnatal lung development in the neonatal rabbit model
Thomas Salaets et al.
RESPIRATORY RESEARCH (2020)
Local pulmonary drug delivery in the preterm rabbit: feasibility and efficacy of daily intratracheal injections
Thomas Salaets et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
Yves Lecarpentier et al.
FRONTIERS IN PEDIATRICS (2019)
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism
Fan Hong et al.
MOLECULES (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Bronchopulmonary dysplasia
Bernard Thebaud et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
European Consensus Guidelines on the Management of Respiratory Distress Syndrome-2019 Update
David G. Sweet et al.
NEONATOLOGY (2019)
A Combination of the Aerosolized PPAR-gamma Agonist Pioglitazone and a Synthetic Surfactant Protein B Peptide Mimic Prevents Hyperoxia-Induced Neonatal Lung Injury Rats
Reiko Sakurai et al.
NEONATOLOGY (2018)
Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model
Amrit Kumar Shrestha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Modelling Bronchopulmonary Dysplasia in Animals: Arguments for the Preterm Rabbit Model
Thomas Salaets et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
Neelaveni Thangavel et al.
INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY (2017)
Transplacental Administration of Rosiglitazone Attenuates Hyperoxic Lung Injury in a Preterm Rabbit Model
Jute Richter et al.
FETAL DIAGNOSIS AND THERAPY (2016)
Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury
Jute Richter et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Progressive Vascular Functional and Structural Damage in a Bronchopulmonary Dysplasia Model in Preterm Rabbits Exposed to Hyperoxia
Julio Jimenez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Transcriptome Analysis of the Preterm Rabbit Lung after Seven Days of Hyperoxic Exposure
Thomas Salaets et al.
PLOS ONE (2015)
The Lung Alveolar Lipofibroblast: An Evolutionary Strategy Against Neonatal Hyperoxic Lung Injury
Virender K. Rehan et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
Bogna Grygiel-Gorniak
NUTRITION JOURNAL (2014)
Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats
Edith Morales et al.
PEDIATRIC RESEARCH (2014)
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-gamma Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
Hyun Ju Lee et al.
YONSEI MEDICAL JOURNAL (2014)
PPAR gamma Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
Virender K. Rehan et al.
PPAR RESEARCH (2012)
Neonatal Respiratory Distress Syndrome: An Inflammatory Disease?
Christian P. Speer
NEONATOLOGY (2011)
Antenatally administered PPAR-γ agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury
Virender K. Rehan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Pathogenesis of Bronchopulmonary Dysplasia
Don Hayes et al.
RESPIRATION (2010)
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-β and Wnt signaling and is protected by rosiglitazone
Chiranjib Dasgupta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Peroxisome Proliferator-Activated Receptor-g Agonist Treatment Increases Septation and Angiogenesis and Decreases Airway Hyperresponsiveness in a Model of Experimental Neonatal Chronic Lung Disease
K. Takeda et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Peroxisome Proliferator-Activated Receptor γ Agonists Enhance Lung Maturation in a Neonatal Rat Model
Ying Wang et al.
PEDIATRIC RESEARCH (2009)
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
Mark A. Deeg et al.
PPAR RESEARCH (2008)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo
Virender K. Rehan et al.
PEDIATRIC PULMONOLOGY (2006)
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
RB Goldberg et al.
DIABETES CARE (2005)
PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production:: implications for therapy of lung fibrosis
HA Burgess et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Thiazolidinediones and blood lipids in type 2 diabetes
JPH van Wijk et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents
GR Madhavan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2001)
分享论文
